COVID-19 vaccination preferences during a pause in Johnson & Johnson vaccine administration
In April 2021, the US paused Janssen (J&J) COVID-19 vaccination because of reported blood clots post vaccination.This paper explores how vaccine decision-making--receiving a J&J vaccine right away vs waiting for a copyright vaccine--changed during the pause.In an opt-in internet-based survey April 2021 with 915 participants, 37 % were not vaccinate